News summary

Vitamin B12 may hold the key to treating a rare genetic disorder

Source: Science Daily - Health & Medicine • Published: 16 Nov 2026, 14:31

Summarized by Masters of Longevity from Science Daily - Health & Medicine.

B12 corrected developmental defects in worm spliceosome mutants and matched patient metabolism.

Vitamin B12 may hold the key to treating a rare genetic disorder
Key Takeaways
  • Vitamin B12 reversed developmental defects in worm spliceosome mutants.
  • B12 altered phospholipid composition to restore membrane balance.
  • Comparable metabolic changes were found in human patients.
Read the full article at Science Daily - Health & Medicine ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.